CIPROFLOXACIN 5% DEXTROSE, INJECTION, 400MG/200ML, (2MG/ML) IS A MEDICAL COUNTERMEASURE (MCM) REQUIRED BY THE SNS
$47,750,653
| Recipient | SAGENT PHARMACEUTICALS, INC UEI PR1HCLM3FMW7 |
|---|---|
| Award ID | 75A50322F80029 |
| Award amount | $47,750,653 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Sep 26, 2022 |
| End date | Dec 29, 2023 |
| Place of performance | SCHAUMBURG, IL |
| Record updated | Sep 6, 2022 |
View the official award record
More awards won by SAGENT PHARMACEUTICALS, INC
CIPROFLOXACIN SOLUTION FOR INJECTION, 400MG/ 200ML FLEXI-BAG
Department of Health and Human Services · $16,638,758 · Sep 30, 2025
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $5,515,517 · May 1, 2024
CIPROFLOXAXIN IVPB
Department of Veterans Affairs · $275,580 · Aug 14, 2026
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids